GS Spacer

EpiNet takes epilepsy research to the internet


Currently no map locations have been configured, please setup the map component

The issue


Epilepsy is very diverse and often of unknown cause.

Drug companies tend to focus on more common forms, hence it has been difficult to organise the required number of study sites and sample size of patients with a particular condition.

The solution


Dr Peter Bergin is taking full advantage of the ‘Internet of Things’ to solve the epilepsy problem that has bedevilled epilepsy researchers for decades.

Dr Bergin, an Auckland City Hospital epileptologist and honorary academic at the University of Auckland Centre for Brain Research, developed the web-based EpiNet platform.

It allows epilepsy specialists to enrol eligible patients in clinical trials from virtually anywhere in the world over the Internet.

Outcomes


EpiNet has the potential to speed international research in epilepsy.

Dr Bergin has already proved the concept with a number of small grants and also has received significant funding from the Health Research Council.

The HRC awarded him a five-year Clinical Practitioner Fellowship - one of only four of this type in New Zealand.

The EpiNet study group is currently planning a series of trials in new-onset epilepsy. These studies are being funded by the Neurological Foundation of New Zealand. See EpiNet for more information.

brain image